Scores here are heuristic signals about sourcing and corroboration across outlets — not verdicts on whether a story is true, and not an endorsement or condemnation of any outlet. How this works
Recommended dose of hepatitis B vaccine will be withheld from thousands of newborns by Danish researchers A controversial research trial that will withhold hepatitis B vaccines from some African newborns was given approval to move forward this week. It is a central part of the vaccine vision for Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS) and a longtime vaccine opponent. Continue reading...
1
independent outlets · 100% owner-diverse
The coverage shows a direct contradiction between reporting on the trial's approval status, citing government ministers versus other researchers. The language used is definitive in each report, but the accounts diverge sharply on the core status of the trial's authorization.
Describes tone and sourcing pattern only — never assesses whether the story is true. See methodology.
Save this story
Connect "Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau" to your own research notes and market positions — Next Level Intelligence links what you save to the assets and notes it actually affects.